Jiaxing Xie1, Nazanin Zounemat
Kermani1,2, Stelios Pavlidis1,2, Kai
Sun2, Yike Guo2, Richard G
Knowles3, Qingling Zhang4, Sven-Erik
Dahlen5, Peter Sterk6, Ratko
Djukanovic7 , Kian Fan Chung1,2, Ian
M. Adcock1,2 on behalf of the U-BIOPRED study
group#
1National Heart and Lung Institute, Imperial College
London, and Biomedical Research Unit, Royal Brompton and Harefield NHS
Trust, London, UK; 2Dept of Computing and Data Science
Institute, Imperial College London, London, UK;3Knowles Consulting, Stevenage Bioscience Catalyst,
Stevenage, UK; 4Pulmonary and Critical Care Medicine,
Guangzhou Institute of Respiratory Health & The First Affiliated
Hospital of Guangzhou Medical University, Guangzhou 510120, China;5Centre for Allergy Research, Karolinska Institute,
Stockholm, Sweden; 6Amsterdam University Medical
Centers, University of Amsterdam, Amsterdam, Netherlands;7NIHR Southampton Respiratory Biomedical Research
Unit, University Hospital Southampton, Southampton, UK .
#The list of U-BIOPRED study group members is
provided in an online supplementary Table.